Translatability of in vitro potency to clinical efficacious exposure: A retrospective analysis of FDA‐approved targeted small molecule oncology drugs

MLA

Naoki Kotani, and Kiyomi Ito. “Translatability of in Vitro Potency to Clinical Efficacious Exposure: A Retrospective Analysis of FDA‐approved Targeted Small Molecule Oncology Drugs.” Clinical and Translational Science, vol. 16, no. 8, Aug. 2023, pp. 1359–68. EBSCOhost, https://doi.org/10.1111/cts.13532.

APA

Naoki Kotani, & Kiyomi Ito. (2023). Translatability of in vitro potency to clinical efficacious exposure: A retrospective analysis of FDA‐approved targeted small molecule oncology drugs. Clinical and Translational Science, 16(8), 1359–1368. https://doi.org/10.1111/cts.13532

Chicago

Naoki Kotani, and Kiyomi Ito. 2023. “Translatability of in Vitro Potency to Clinical Efficacious Exposure: A Retrospective Analysis of FDA‐approved Targeted Small Molecule Oncology Drugs.” Clinical and Translational Science 16 (8): 1359–68. doi:10.1111/cts.13532.